Mitomycin-induced thrombotic thrombocytopenic purpura: possible successful treatment with vincristine and cyclophosphamide

Haematologica. 1991 Sep-Oct;76(5):421-3.

Abstract

The findings and management of a patient with the mitomycin-induced syndrome of thrombotic thrombocytopenic purpura (TTP) is reported. Hyperreactivity of the cytotoxic suppressor T-cell was found. Vincristine and cyclophosphamide reversed the hematologic and renal dysfunction after administration of antiplatelet agents and plasma infusion had failed to do so.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Doxorubicin / administration & dosage
  • Drug Therapy, Combination
  • Fluorouracil / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Mitomycin / administration & dosage
  • Mitomycin / adverse effects*
  • Neoplasms, Unknown Primary / drug therapy
  • Plasma
  • Purpura, Thrombotic Thrombocytopenic / chemically induced*
  • Purpura, Thrombotic Thrombocytopenic / drug therapy
  • Purpura, Thrombotic Thrombocytopenic / immunology
  • Purpura, Thrombotic Thrombocytopenic / mortality
  • T-Lymphocytes, Regulatory / pathology
  • Ticlopidine / therapeutic use
  • Vincristine / administration & dosage
  • Vincristine / therapeutic use*

Substances

  • Mitomycin
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Ticlopidine
  • Fluorouracil